Biogen Inc. buy Morgan Stanley
Start price
11.10.23
/
50%
€252.00
Target price
11.10.24
€339.70
Performance (%)
-18.37%
Price
10.05.24
€205.70
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.37%. This prediction currently runs until 11.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 1.781% | 1.781% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Morgan Stanley from $381.00 to $361.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat